Ramin Alipour

915 total citations
26 papers, 270 citations indexed

About

Ramin Alipour is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Ramin Alipour has authored 26 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Oncology. Recurrent topics in Ramin Alipour's work include Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Medical Imaging Techniques and Applications (8 papers). Ramin Alipour is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Radiopharmaceutical Chemistry and Applications (14 papers) and Medical Imaging Techniques and Applications (8 papers). Ramin Alipour collaborates with scholars based in Australia, United States and United Kingdom. Ramin Alipour's co-authors include Michael S. Hofman, Arun Azad, Rodney J. Hicks, Sandeep K. Gupta, Mathias Bressel, Grace Kong, Shahneen Sandhu, Anthony M. Joshua, Louise Emmett and Megan Crumbaker and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Ramin Alipour

22 papers receiving 269 citations

Peers

Countries citing papers authored by Ramin Alipour

Since Specialization

Citations

This map shows the geographic impact of Ramin Alipour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramin Alipour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramin Alipour more than expected).

Fields of papers citing papers by Ramin Alipour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramin Alipour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramin Alipour. The network helps show where Ramin Alipour may publish in the future.

Co-authorship network of co-authors of Ramin Alipour

This figure shows the co-authorship network connecting the top 25 collaborators of Ramin Alipour. A scholar is included among the top collaborators of Ramin Alipour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramin Alipour. Ramin Alipour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence and Medium-Term Outcomes of Patients with Biopsy-Proven Intermediate- to High-Risk Prostate Adenocarcinoma with Low Intraprostatic Uptake on [⁶⁸Ga]Ga-PSMA-11 PET/CT in the proPSMA Study 2025 ·Journal of Nuclear Medicine ·David C. Chen, James P Buteau, Louise Emmett, Ramin Alipour, Felipe de Galiza Barbosa, Matthew J. Roberts, (unknown), J O’Brien, Sidney M. Levy, Roslyn J. Francis, Nathan Lawrentschuk, Declan G. Murphy, Michael S. Hofman	1
2	Safety and efficacy of re-treatment with [177Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours – a single centre experience 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·Raghava Kashyap, Ramin Alipour, Emma Boehm, (unknown), (unknown), (unknown), Javad Saghebi, Michael S. Hofman, Michael Fahey, Michael Michael, Tim Akhurst, Rodney J. Hicks, Grace Kong	1
3	2391P LuPARP: Phase I trial of [177Lu]Lu-PSMA-617 (LuPSMA) and olaparib in patients (pts) with metastatic castration resistant prostate cancer (mCRPC) 2025 ·Annals of Oncology ·Simran Sandhu, (unknown), (unknown), Megan Crumbaker, (unknown), (unknown), Joanna Chan, Patricia Banks, Ryan Wallace, Anis Hamid, (unknown), Ramin Alipour, George Kong, (unknown), Ben Tran, Sofie H. Tolmeijer, (unknown), (unknown), (unknown), (unknown)	0
4	Deep Learning for Automated Measures of SUV and Molecular Tumor Volume in [ ⁶⁸ Ga]PSMA-11 or [ ¹⁸ F]DCFPyL, [ ¹⁸ F]FDG, and [ ¹⁷⁷ Lu]Lu-PSMA-617 Imaging with Global Threshold Regional Consensus Network 2025 ·Journal of Nuclear Medicine ·Price Jackson, James P Buteau, Lachlan McIntosh, Y. Sun, Raghava Kashyap, (unknown), Aravind S. Ravi Kumar, Shahneen Sandhu, Arun Azad, Ramin Alipour, Javad Saghebi, Grace Kong, (unknown), Michal Eifer, (unknown), Michael S. Hofman	0
5	¹⁷⁷ Lu-PSMA-617 with ipilimumab (ipi) and nivolumab (nivo) in metastatic castration-resistant prostate cancer (mCRPC): An investigator-initiated phase 2 trial (EVOLUTION; ANZUP2001). 2025 ·Journal of Clinical Oncology ·Shahneen Sandhu, Shalini Subramaniam, (unknown), Thean Hsiang Tan, Jeffrey C. Goh, Nattakorn Dhiantravan, Andrew Weickhardt, Anthony M. Joshua, Ian Kirkwood, Sze Ting Lee, Craig Gedye, Andrew Nguyen, David A. Pattison, Ramin Alipour, Roslyn J. Francis, Michael S. Hofman, Andrew Martin, Martin R. Stockler, Ian D. Davis, Louise Emmett, (unknown)	3
6	Quantitative calibration of Tb-161 SPECT/CT in view of personalised dosimetry assessment studies 2024 ·EJNMMI Physics ·Lachlan McIntosh, Price Jackson, (unknown), James P Buteau, Ramin Alipour, Grace Kong, Michael S. Hofman	7
7	Peptide receptor radionuclide therapy for ectopic Cushing’s syndrome caused by metastatic neuroendocrine neoplasms 2024 ·SHILAP Revista de lepidopterología ·Emma Boehm, (unknown), Tim Akhurst, Ramin Alipour, Cherie Chiang, Rodney J. Hicks, Michael S. Hofman, Aravind S. Ravi Kumar, Nirupa Sachithanandan, Javad Saghebi, Michael Michael, Grace Kong	0
8	1608P Prostate cancer working group 4 (PCWG4) preliminary criteria using serial PSMA PET/CT for response evaluation: Analysis from the PRINCE trial 2024 ·Annals of Oncology ·Michael S. Hofman, (unknown), (unknown), Ramin Alipour, Sidney M. Levy, (unknown), (unknown), Anis Hamid, (unknown), Phillip H. Kuo, D.L. Chen, Thomas A. Hope, (unknown), (unknown), (unknown), Simran Sandhu, (unknown)	2
9	Role of neoadjuvant peptide receptor radionuclide therapy in unresectable and metastatic gastro‐entero‐pancreatic neuroendocrine neoplasms: A scoping review 2024 ·Journal of Neuroendocrinology ·Raghava Kashyap, (unknown), (unknown), G. M. Reddy, Benjamin Loveday, Ramin Alipour, Grace Kong	1
10	Comparison of quantitative whole body PET parameters on [68Ga]Ga-PSMA-11 PET/CT using ordered Subset Expectation Maximization (OSEM) vs. bayesian penalized likelihood (BPL) reconstruction algorithms in men with metastatic castration-resistant prostate cancer 2024 ·Cancer Imaging ·Narjess Ayati, Lachlan McIntosh, James P Buteau, Ramin Alipour, (unknown), (unknown), Price Jackson, Michael S. Hofman	1
11	Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [¹⁶¹Tb]Tb-PSMA-I&T 2024 ·Journal of Nuclear Medicine ·James P Buteau, Louise Kostos, Ramin Alipour, Price Jackson, (unknown), (unknown), Mohammad B. Haskali, Jing Xie, (unknown), (unknown), Brian D. Gonzalez, Heidi Fettke, Benjamin J. Blyth, Luc Furic, Katie L. Owen, Shahneen Sandhu, Declan G. Murphy, Arun Azad, Michael S. Hofman	11
12	Evolution: Phase II study of radionuclide ¹⁷⁷Lu-PSMA-617 therapy versus ¹⁷⁷Lu-PSMA-617 in combination with ipilimumab and nivolumab for men with metastatic castration-resistant prostate cancer (mCRPC; ANZUP 2001). 2023 ·Journal of Clinical Oncology ·Shahneen Sandhu, Shalini Subramaniam, Michael S. Hofman, Martin R. Stockler, Andrew Martin, Izabella Pokorski, Jeffrey C. Goh, David A. Pattison, Nattakorn Dhiantravan, Craig Gedye, Natalie Rutherford, Anthony M. Joshua, Thean Hsiang Tan, Ian Kirkwood, Sze Ting Lee, Andrew Weickhardt, Ramin Alipour, Andrew Nguyen, Ian D. Davis, Louise Emmett, (unknown)	17
13	The relationship between tumour dosimetry, response, and overall survival in patients with unresectable Neuroendocrine Neoplasms (NEN) treated with 177Lu DOTATATE (LuTate) 2023 ·European Journal of Nuclear Medicine and Molecular Imaging ·Ramin Alipour, Price Jackson, Mathias Bressel, Annette Hogg, Jason Callahan, Rodney J. Hicks, Grace Kong	21
14	QUAD SHOT Radiotherapy and Doublet Immunotherapy in the Management of Anal Mucosal Melanoma: A Case Series of Efficacy and Toxicity of a Novel Treatment Approach and a Review of the Literature 2022 ·Clinical Colorectal Cancer ·(unknown), Ramin Alipour, (unknown), Kjell–Arne Ung, David L. Kok, (unknown)	3
15	PET/CT variants and pitfalls in malignant melanoma 2022 ·Cancer Imaging ·Nicolas Aide, Amir Iravani, (unknown), D. Kottler, Ramin Alipour, Rodney J. Hicks	19
16	PRINCE: Phase I trial of ¹⁷⁷Lu-PSMA-617 in combination with pembrolizumab in patients with metastatic castration-resistant prostate cancer (mCRPC). 2022 ·Journal of Clinical Oncology ·Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Lavinia Spain, Lisa G. Horvath, Megan Crumbaker, A. Antón, Roslyn Wallace, Anupama Pasam, Mathias Bressel, (unknown), Patricia Banks, Nattakorn Dhiantravan, Timothy Akhurst, Aravind Ravi Kumar, Ramin Alipour, Mark Scalzo, Scott Williams, Rodney J. Hicks, Michael S. Hofman	34
17	Nodal metabolic tumour volume on baseline ¹⁸F‐FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative‐intent chemoradiotherapy/radiotherapy 2021 ·Journal of Medical Imaging and Radiation Oncology ·Ramin Alipour, (unknown), Mathias Bressel, Sarah Everitt, Michael MacManus, Shankar Siva, Michael S. Hofman, Tim Akhurst, Rodney J. Hicks, Amir Iravani	2
18	577O PRINCE: Interim analysis of the phase Ib study of 177Lu-PSMA-617 in combination with pembrolizumab for metastatic castration resistant prostate cancer (mCRPC) 2021 ·Annals of Oncology ·Shahneen Sandhu, Anthony M. Joshua, Louise Emmett, Lavinia Spain, Lisa G. Horvath, Megan Crumbaker, A. Antón, Roslyn Wallace, Anupama Pasam, Mathias Bressel, (unknown), Patricia Banks, Aravind Ravi Kumar, Ramin Alipour, Timothy Akhurst, Grace Kong, Ian D. Davis, Scott Williams, Rodney J. Hicks, Michael S. Hofman	14
19	The role of 18F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co‐infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant 2020 ·Transplant Infectious Disease ·(unknown), Ramin Alipour, Amit Khot, Ashish Bajel, Phillip Antippa, Monica A. Slavin, Karin Thursky	10
20	68Ga-PSMA Uptake in Combined Hepatocellular Cholangiocarcinoma With Skeletal Metastases 2017 ·Clinical Nuclear Medicine ·Ramin Alipour, Sandeep K. Gupta, (unknown)	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact